Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies
- PMID: 18782827
- DOI: 10.1258/la.2007.06014e
Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies
Abstract
Cystic fibrosis (CF) is caused by a defect in the transmembrane conductance regulator (CFTR) protein that functions as a chloride channel. Dysfunction of the CFTR protein results in salty sweat, pancreatic insufficiency, intestinal obstruction, male infertility and severe pulmonary disease. In most patients with CF life expectancy is limited due to a progressive loss of functional lung tissue. Early in life a persistent neutrophylic inflammation can be demonstrated in the airways. The cause of this inflammation, the role of CFTR and the cause of lung morbidity by different CF-specific bacteria, mostly Pseudomonas aeruginosa, are not well understood. The lack of an appropriate animal model with multi-organ pathology having the characteristics of the human form of CF has hampered our understanding of the pathobiology and chronic lung infections of the disease for many years. This review summarizes the main characteristics of CF and focuses on several available animal models that have been frequently used in CF research. A better understanding of the chronic lung infection caused particularly by P. aeruginosa, the pathophysiology of lung inflammation and the pathogenesis of lung disease necessitates animal models to understand CF, and to develop and improve treatment.
Similar articles
-
Infection and inflammation in cystic fibrosis: a short review.J Cyst Fibros. 2005 Aug;4 Suppl 2:3-5. doi: 10.1016/j.jcf.2005.05.005. J Cyst Fibros. 2005. PMID: 15970469 Review.
-
Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls.Physiol Genomics. 2006 Apr 13;25(2):179-93. doi: 10.1152/physiolgenomics.00206.2005. Epub 2006 Jan 17. Physiol Genomics. 2006. PMID: 16418321
-
Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.Am J Respir Crit Care Med. 2009 Jul 15;180(2):138-45. doi: 10.1164/rccm.200812-1943OC. Epub 2009 May 7. Am J Respir Crit Care Med. 2009. PMID: 19423715
-
Pseudomonas aeruginosa infection of respiratory epithelium in a cystic fibrosis xenograft model.J Infect Dis. 2001 Mar 15;183(6):919-27. doi: 10.1086/319245. Epub 2001 Feb 15. J Infect Dis. 2001. PMID: 11237809
-
The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.FEMS Microbiol Lett. 2009 Jan;290(1):1-9. doi: 10.1111/j.1574-6968.2008.01394.x. Epub 2008 Oct 29. FEMS Microbiol Lett. 2009. PMID: 19016870 Review.
Cited by
-
A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection.Sci Rep. 2016 Nov 2;6:35838. doi: 10.1038/srep35838. Sci Rep. 2016. PMID: 27804985 Free PMC article.
-
Control of the Lung Residence Time of Highly Permeable Molecules after Nebulization: Example of the Fluoroquinolones.Pharmaceutics. 2020 Apr 23;12(4):387. doi: 10.3390/pharmaceutics12040387. Pharmaceutics. 2020. PMID: 32340298 Free PMC article. Review.
-
Pathophysiological changes induced by Pseudomonas aeruginosa infection are involved in MMP-12 and MMP-13 upregulation in human carcinoma epithelial cells and a pneumonia mouse model.Infect Immun. 2015 Dec;83(12):4791-9. doi: 10.1128/IAI.00619-15. Epub 2015 Oct 5. Infect Immun. 2015. PMID: 26438797 Free PMC article.
-
The fermentation product 2,3-butanediol alters P. aeruginosa clearance, cytokine response and the lung microbiome.ISME J. 2016 Dec;10(12):2978-2983. doi: 10.1038/ismej.2016.76. Epub 2016 May 14. ISME J. 2016. PMID: 27177192 Free PMC article.
-
A decade of Burkholderia cenocepacia virulence determinant research.Infect Immun. 2010 Oct;78(10):4088-100. doi: 10.1128/IAI.00212-10. Epub 2010 Jul 19. Infect Immun. 2010. PMID: 20643851 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical